• 

  Nearly 1,500 initial volunteers for Oxford Covid vaccine given wrong doses, reveals letter

  World | February 02, 2021 7:20 IST

  The dosing mishap was presented to the trial participants in a letter dated June 8 as an opportunity for University of Oxford researchers to learn how well the vaccine works at different doses. The letter was signed by the trial's chief investigator, Oxford professor Andrew J. Pollard

• 

  'Covishield' ready to roll out in coming weeks: Adar Poonawalla

  India | January 03, 2021 12:08 IST

  Poonawalla'' remarks came soon after after India's drugs regulator, Drug Controller General of India (DCGI) approved Covishield for restricted emergency use.

• 

  Oxford-AstraZeneca COVID-19 vaccine gets recommendation for emergency use

  India | January 01, 2021 23:28 IST

  An expert panel on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended to grant emergency use authorisation for the Oxford COVID-19 vaccine Covishield, being manufactured by Serum Institute of India, sources said on Friday.

• 

  Here's what you need to know about Oxford Covid-19 vaccine

  World | January 01, 2021 13:55 IST

  Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, is manufacturing a version of the Oxford-AstraZeneca Covid-19 vaccine "Covishield" in India.

• 

  Oxford-AstraZeneca vaccine should be effective against new COVID variant, says report

  India | December 27, 2020 21:49 IST

  The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, a UK media report said on Sunday.

• 

  Oxford COVID-19 vaccine may become the first to get Indian regulator's nod for emergency use

  India | December 26, 2020 17:58 IST

  With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford COVID-19 vaccine next week, before deciding on giving emergency use authorisation to the Serum Institute that is manufacturing the shots here.

• 

  Oxford-AstraZeneca coronavirus vaccine set to be cleared by year-end

  Good News | December 19, 2020 16:44 IST

  The Oxford University vaccine against COVID-19 being produced by AstraZeneca is likely to get regulatory approval from the UK’s independent regulator by the end of this year for a rollout to begin in early 2021, according to a UK media report. 

• 

  'Covid-19 vaccine has better immune response with two full-dose regime'

  Science | December 18, 2020 9:42 IST

  Oxford University on Thursday said that its COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster.

• 

  Oxford-AstraZeneca in ‘mix-match’ COVID-19 vaccine trial with Russia’s Sputnik

  World | December 12, 2020 21:40 IST

  The Oxford University and AstraZeneca COVID-19 vaccine, currently awaiting regulatory approvals, is set to be used for a “mix and match” trial with Russia’s Sputnik vaccine against the novel coronavirus, according to UK media reports.

• 

  Only India can satisfy world's Covid vaccine needs: Foreign envoys after Bharat Biotech tour

  India | December 09, 2020 18:18 IST

  Australian Ambassador to India Barry O'Farrell lauded the country's effort on development of a vaccine against coronavirus saying, "There're many vaccines being produced in countries around the world but there's only one country that has the manufacturing capacity to produce sufficient quantities to satisfy the demands of citizens in every country & that's India."

• 

  UK asks regulator to approve Oxford-AstraZeneca vaccine

  World | November 27, 2020 17:34 IST

  The UK government said on Friday that it has formally asked the country's independent medicines regulator to assess the suitability of Oxford-AstraZeneca’s COVID-19 vaccine for temporary supply, as soon as the company submits the necessary safety, quality and efficacy data.

Advertisement
• 

  Oxford vaccine safe, says Serum Institute after AstraZeneca admits manufacturing error

  India | November 26, 2020 23:13 IST

  Vaccine major Serum Institute of India on Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly with strict adherence to all protocols.

• 

  Indian economy may be recovering faster than anticipated: Oxford Economics

  Business | November 15, 2020 11:48 IST

  The Indian economy is seen recovering faster than expected and the Reserve Bank is likely to have come to an end of the rate easing cycle, according to global forecasting firm Oxford Economics. 

• 

  India will get 100 million Oxford vaccine shots by December: Adar Poonawalla

  India | November 14, 2020 8:30 IST

  ​Serum Institute of India, the world's largest vaccine maker, is ramping up production of AstraZeneca's Covid-19 shot to have 100 million doses ready by December for an inoculation drive expected to begin across India that same month.

• 

  Oxford-AstraZeneca coronavirus vaccine producing immune response in young, old adults

  Good News | October 26, 2020 23:20 IST

  Oxford-AstraZeneca coronavirus vaccine, one of the leading vaccine candidates out there and undergoing final stage phase 3 clinical trials, is producing immune response in young and old adults.

• 

  Oxford-developed COVID-19 vaccine to be rolled out in 3 months in UK: Report

  World | October 04, 2020 12:24 IST

  The Oxford University-developed coronavirus vaccine could be rolled out within three months in the UK, news agency IANS quoted the Times as saying.

• 

  PGI Chandigarh begins clinical trials of Oxford vaccine; three volunteers administered first dose

  India | September 26, 2020 7:36 IST

  The Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, has administered the first dose of Oxford Covid-19 vaccine -- Covishield -- to three candidates on Friday, informed PGI Chandigarh Director Prof Jagat Ram. 

• 

  'Shouldn't jump to conclusions', Adar Poonawalla says as Oxford resumes COVID vaccine trials

  India | September 13, 2020 8:29 IST

  Just as biopharmaceutical giant AstraZeneca and the University of Oxford on Saturday announced that clinical trials for their coronavirus vaccine have resumed in the UK, Adar Poonawalla advised all to not jump to conclusions until completion of the process. Poonawalla is the chief executive officer of the vaccine's local manufacturer Serum Institute of India (SII).

• 

  Serum Institute gets DCGI notice for not informing AstraZeneca pausing vaccine trials abroad

  India | September 09, 2020 23:26 IST

  The Serum Institute of India (SII), which is conducting Oxford-AstraZeneca coronavirus vaccine phase 2 and 3 trials in India, has received a show-cause notice from the central drug regulator for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford vaccine candidate in other countries and also for not submitting casualty analysis of the "reported serious adverse events".

• 

  SII responds on Indian trials of Oxford-AstraZeneca coronavirus vaccine after they were halted in UK

  India | September 09, 2020 16:34 IST

  The Serum Institute of India (SII), which is conducting Oxford-AstraZeneca coronavirus vaccine phase 2-3 trials in India, has said that the Indian trials of the vaccine are continuing and they can't comment on the UK trials which have been paused after a patient developed unexplained illness.